Business Daily from THE HINDU group of publications
Saturday, Oct 11, 2008
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Saturday, Oct 11, 2008 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate
-
Regulatory Bodies & Rulings Aurobindo drug gets US nod Hyderabad, Oct. 10 Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Cyclobenzaprine Hydrochloride tablets in 5 mg and 10 mg. The tablet is the generic version of Mcneil-PPC's Flexeril tablets (5 mg and 10 mg). It is indicated as an adjunct for relief of muscle spasm. The approval was the 79th Abbreviated New Drug Application (ANDA) from USFDA, according to a release. - Our BureauMore Stories on : Regulatory Bodies & Rulings | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
